Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-01-30
2007-01-30
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S178000, C514S236200, C514S310000, C514S324000, C514S428000, C514S448000, C514S470000, C514S565000
Reexamination Certificate
active
09089583
ABSTRACT:
A method of decreasing atherosclerosis and its complications including but not limited to myocardial infarction, stroke and peripheral vascular disease wherein the method involves administering to a human or an animal an amount of an inhibitor of the release of LHRH or GnRH.
REFERENCES:
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5872114 (1999-02-01), Labrie
patent: 5906987 (1999-05-01), Chwalisz et al.
patent: 6099851 (2000-08-01), Weisman et al.
patent: 6140315 (2000-10-01), Weisman et al.
patent: 6197337 (2001-03-01), Weisman et al.
patent: 9608239 (1996-03-01), None
Goodman and Gilman's Pharmacological Basis of Therapeutics, pp. 1427-1429, 1980.
Goldberg Michael
Weisman Kenneth M.
Caesar Rivise Bernstein Cohen & Pokotilow Ltd.
Owens, Jr. Howard V.
Wilson James O.
LandOfFree
Method of decreasing atherosclerosis and its complications does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of decreasing atherosclerosis and its complications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of decreasing atherosclerosis and its complications will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3744512